Insider trades

Sharp Phillip A., Director of Alnylam Pharmaceuticals ALNY, has filed 0 purchases and 7 sales on the open market. The latest trade was on 25/01/23.

Sharp Phillip A.

Director
First filing
23/05/19
Trades
15 trades
Buys / sales
0 / 7
12-month net buying
No record
Last trade
25/01/23

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan25/01/2325/01/2411,250 sh$275.00$3,093,750−100.0%
ALNY
Open-market sale10b5-1 plan24/02/2924/03/0130,000 sh6 trades$151.34avg.$4,540,070.94−100.0%